Beneficial effects of Helicobacter pylori eradication on migraine: A 12-month follow-up study

Journal of Headache and Pain

Volumn 2, Issue 1, 2001, Pages 39-43

  Gabrielli, Maurizio ^a   Franceschi, Francesco ^a   Fiore, Giuseppe ^b   Candelli, Marcello ^a   Armuzzi, Alessandro ^a   Ojetti, Veronica ^a   Cremonini, Filippo ^a   Pola, Paolo ^a   Giacovazzo, Mario ^b   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cytotoxins; Helicobacter pylori; Migraine; Vasospasm

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CARBON 13; CLARITHROMYCIN; PROTON PUMP INHIBITOR; UREA;

ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MIGRAINE; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; SYMPTOM; VASCULAR DISEASE;

EID: 0034978189     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012185     Document Type: Article

References (36)

1. Migraine
2. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
3. Migraine impact and functional disability
4. Migraine: Theories of pathogenesis
5. H. pylori
6. A population based study of H. pylori infection in a European country: The San Marino study. Relations with gastrointestinal diseases
7. The role of Helicobacter pylori in primary gastric MALT lymphoma
8. Helicobacter pylori infection and gastric cancer: Systematic review of the epidemiological studies
9. Association of H. pylori infection with Raynaud phenomenon
10. Primary headache and Helicobacter pylori
11. Beneficial effects of Helicobacter pylori eradication on migraine
12. Relation of H. pylori infection and coronary heart disease
13. Association of H. pylori and Clamydia pneumoniae infection with coronary heart disease and cardiovascular risk factors
14. Association of virulent Helicobacter pylori strains with ischaemic heart disease
15. Helicobacter pylori infection and vascular diseases
16. Extradigestive manifestations of Helicobacter pylori gastric infection
17. Mucosal tumor necrosis factor alpha and interleukin-6 in patients with H. pylori associated gastritis
18. Immune and inflammatory responses to H. pylori infection
19. Helicobacter pylori and gastric inflammation
20. Mechanisms involved in H. pylori-induced inflammation
21. pylori-induced microvascular protein leakage in rats: Role of neutrophils, mast cells and platelets
22. Chemokines in the gastric mucosa in H. pylori infection
23. Microbiological aspects of H. pylori
24. Eicosanoid synthesis and H. pylori associated gastritis: Increase in leukotriene C4 generation associated with H. pylori colonization
25. Inflammation in ischaemic heart disease
26. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
27. Migraine chronobiology
28. Precipitating factors in migraine: A retrospective review of 494 patients
29. A study of the seasonal variation of migraine
30. 13C urea breath test
31. Le cefalee
32. Headache symptoms and psycological profile of headache-prone individuals. A comparison of clinic patients and controls
33. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
34. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach
35. The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-alpha, and their common receptor
36. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy